Plus therapeutics completes phase 1/part a of the respect-lm clinical trial for leptomeningeal metastases

The company plans to meet with u.s. fda to discuss next steps for the phase 1/part b trial in the third quarter of 2023
pstv Ratings Summary
pstv Quant Ranking